Risk assessment of parabens in a transcriptomics-based in vitro test.
Alternative testing strategies
Developmental and reproductive toxicity
Gene expression
In vitro test
Induced pluripotent stem cells
Parabens
Toxicogenomics
Transcriptomics
Journal
Chemico-biological interactions
ISSN: 1872-7786
Titre abrégé: Chem Biol Interact
Pays: Ireland
ID NLM: 0227276
Informations de publication
Date de publication:
01 Oct 2023
01 Oct 2023
Historique:
received:
01
08
2023
accepted:
07
09
2023
pubmed:
11
9
2023
medline:
11
9
2023
entrez:
10
9
2023
Statut:
ppublish
Résumé
Parabens have been used for decades as preservatives in food, drugs and cosmetics. The majority however, were banned in 2009 and 2014 leaving only methyl-, ethyl-, propyl-, and butyl-derivates available for subsequent use. Methyl- and propylparaben have been extensively tested in vivo, with no resulting evidence for developmental and reproductive toxicity (DART). In contrast, ethylparaben has not yet been tested for DART in animal experiments, and it is currently debated if additional animal studies are warranted. In order to perform a comparison of the four currently approved parabens, we used a previously established in vitro test based on human induced pluripotent stem cells (iPSC) that are exposed to test substances during their differentiation to neuroectodermal cells. EC
Identifiants
pubmed: 37690743
pii: S0009-2797(23)00366-6
doi: 10.1016/j.cbi.2023.110699
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110699Informations de copyright
Copyright © 2023. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of competing interest The parabens tested in this study were provided by Clariant Produkte (Deutschland) GmbH. Companies of the Clariant Group produce and market parabens, among other products. Susann Fayyaz and Reinhard Kreiling are employees of Clariant Produkte (Deutschland) GmbH.